What is Cell Microsystems?
Cell Microsystems specializes in creating sophisticated instruments for the precise imaging, sorting, and isolation of individual cells and colonies. Their innovative product suite, including the CellRaft AIR System, is engineered to enhance clonal outgrowth and facilitate high-throughput cellular analysis. The company's technology is instrumental for researchers in prominent institutions and pharmaceutical firms, enabling breakthroughs in diverse biological applications and supporting advancements in 3D cell culture and automated cell counting.
How much funding has Cell Microsystems raised?
Cell Microsystems has raised a total of $14.6M across 4 funding rounds:
Grant
$1.5M
Debt
$150K
Debt
$292K
Other Financing Round
$12.7M
Grant (2018): $1.5M, investors not publicly disclosed
Debt (2020): $150K led by PPP
Debt (2021): $292K supported by PPP
Other Financing Round (2021): $12.7M featuring Telegraph Hill Partners
Key Investors in Cell Microsystems
Telegraph Hill Partners
Telegraph Hill Partners is a venture capital firm founded in 2001, based in San Francisco, CA, that specializes in investing in commercial-stage life science, medical technology, and healthcare companies.
What's next for Cell Microsystems?
The substantial enterprise-level backing positions Cell Microsystems for accelerated growth and expanded market penetration. This capital infusion is expected to fuel further development of their cutting-edge cell analysis platforms and strengthen their research and development capabilities. The company's focus on enabling high-throughput cellular isolation and imaging suggests a trajectory aimed at becoming a dominant player in the life science tools sector, supporting critical research initiatives and driving innovation in biotechnology.
See full Cell Microsystems company page
